Tetanus — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for tetanus. 21 active patents protecting 1 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

1
Approved drugs
21
Active US patents
67/100
Avg vulnerability
—
Annual revenue covered

Originators in Tetanus

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Roche) 21 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating tetanus. Each bar = one year. Y-axis scaled to peak year (15 patents).

15
29
6
32

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Valium
diazepam
 Generic (originally Roche) 21 67 — 2029-03-27

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12337061 Valium method of use 75 2032-06-13
12337061 Valium method of use 75 2032-06-13
12337061 Valium method of use 75 2032-06-13
12324852 Valium method of use 75 2032-10-16
12324852 Valium method of use 75 2032-10-16
12324852 Valium method of use 75 2032-10-16
12268664 Valium formulation 68 2029-03-27
12521400 Valium formulation 68 2029-03-27
12521400 Valium formulation 68 2029-03-27
12521400 Valium formulation 68 2029-03-27

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8895546 Valium formulation 55 2029-03-27
8895546 Valium formulation 55 2029-03-27
8895546 Valium formulation 55 2029-03-27
11793786 Valium formulation 63 2029-03-27
11793786 Valium formulation 63 2029-03-27
11793786 Valium formulation 63 2029-03-27
11241414 Valium formulation 63 2029-03-27
11241414 Valium formulation 63 2029-03-27
11241414 Valium formulation 63 2029-03-27
12268664 Valium formulation 68 2029-03-27

Related